Stockholders' Equity (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |
|---|---|---|---|---|
Jun. 30, 2019 |
Jun. 30, 2020 |
Dec. 31, 2019 |
Jun. 02, 2020 |
|
| Number of awards oustanding | 1,722,779 | 1,639,167 | ||
| Number of awards granted | 84,445 | |||
| Unrecognized compensation expense | $ 948,807 | |||
| Compensation expense, period for recognition | 1 year 6 months | |||
| Offering costs | $ 94,162 | |||
| Term of warrants | 5 years | |||
| Securities Purchase Agreement (the "2019 PIPE") | Accredited Investors | ||||
| Sale of stock, number of shares issued | 2,426,455 | |||
| Offering costs | $ 94,000 | |||
| Share price (in dollars per share) | $ 3.10 | |||
| Proceeds from issuance of stock | $ 7,500,000 | |||
| Amended and Restated 2013 Incentive Compensation Plan | ||||
| Common stock reserved for issuance | 2,956,250 | |||
| Number of share available for grant | 1,339,576 | |||
| Number of awards oustanding | 1,175,679 | |||
| Number of awards granted | 440,995 | |||
| Third Amended and Restated 2013 Incentive Compensation Plan | ||||
| Common stock reserved for issuance | 1,000,000 |
| X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|